Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 8Recruiting 3Withdrawn 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 4Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Other 1Genitourinary 1

Conditions

Pancreatic Neoplasms 1Cholangiocarcinoma 1

Interventions

Oxaliplatin 95Fluorouracil 84Capecitabine 75Gemcitabine 72Leucovorin 68Nivolumab 67Bevacizumab 63pembrolizumab 60Magnetic Resonance Spectroscopy 52Specimen Handling 50Irinotecan 50durvalumab 46Radiotherapy 42atezolizumab 40Cisplatin 39Paclitaxel 37Biopsy 37130-nm albumin-bound paclitaxel 34Cetuximab 30Carboplatin 27Albumin-Bound Paclitaxel 26Taxes 24Drug Therapy 20dehydroftorafur 19Radiation 19Ipilimumab 19tislelizumab 18Surgical Procedures, Operative 17Standard of Care 17Docetaxel 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Resistance Training × Gastrointestinal × Clear all
NCT04837118 2026-04-15

Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study

M.D. Anderson Cancer Center

Phase NA Active not recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05921552 2025-12-04

Senior Adult Hepatobiliary Prehab Study

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Active not recruiting
25 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡